earnings
confidence high
sentiment positive
materiality 0.80
Amphastar Q2 2022 net revenue up 21.5% YoY to $123.5M; GAAP EPS $0.33
Amphastar Pharmaceuticals, Inc.
2022-Q2 EPS reported
$0.79
revenue$243,835,000
- Net revenues $123.5M for Q2 2022, up from $101.7M in Q2 2021 (21.5% increase).
- GAAP net income $17.3M ($0.33 diluted EPS) vs $7.8M ($0.16) in Q2 2021.
- Adjusted non-GAAP net income $20.7M ($0.39 diluted EPS) vs $10.6M ($0.21) in Q2 2021.
- CEO cites strong sales momentum; expects continued growth from ganirelix and vasopressin launch.